379 related articles for article (PubMed ID: 31535758)
1. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
[TBL] [Abstract][Full Text] [Related]
2. Late-onset hidradenitis suppurativa: A cluster analysis of the National Italian Registry IRHIS.
Cazzaniga S; Pezzolo E; Garcovich S; Naldi L;
J Am Acad Dermatol; 2021 Jul; 85(1):e29-e32. PubMed ID: 33677001
[No Abstract] [Full Text] [Related]
3. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.
Giovanardi G; Chiricozzi A; Bianchi L; De Simone C; Dini V; Franceschini C; Garcovich S; Oranges T; Di Raimondo C; Caposiena Caro DR; Romanelli M; Peris K
Dermatology; 2018; 234(1-2):66-70. PubMed ID: 29689550
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa: Epidemiology and scope of the problem.
Jemec GB; Kimball AB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
Kucinskiene V; Jariene V; Valiukeviciene S
Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
[TBL] [Abstract][Full Text] [Related]
6. Registries, multicentre and genome-wide association studies in hidradenitis suppurativa.
Jemec GBE; Del Marmol V; Bettoli V; Augustin M; Prens EP; Zouboulis CC
Exp Dermatol; 2022 Sep; 31 Suppl 1():22-28. PubMed ID: 35582836
[TBL] [Abstract][Full Text] [Related]
7. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS.
Cazzaniga S; Pezzolo E; Bettoli V; Abeni D; Marzano AV; Patrizi A; Atzori L; Fabbrocini G; Offidani A; Lasagni C; Dini V; Caproni M; Cannavò SP; Naldi L
J Invest Dermatol; 2021 May; 141(5):1236-1242.e1. PubMed ID: 33098826
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
[TBL] [Abstract][Full Text] [Related]
10. Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry.
Bettoli V; Naldi L; Cazzaniga S; Zauli S; Atzori L; Borghi A; Capezzera R; Caproni M; Cardinali C; De Vita V; Donini M; Fabbrocini G; Gimma A; Pasquinucci S; Patrizi A; Pinna AL; Raone B; Ricci M; Virgili A; Balestri R
Br J Dermatol; 2016 Jan; 174(1):195-7. PubMed ID: 25913460
[No Abstract] [Full Text] [Related]
11. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.
Calao M; Wilson JL; Spelman L; Billot L; Rubel D; Watts AD; Jemec GBE
PLoS One; 2018; 13(7):e0200683. PubMed ID: 30040827
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.
Killasli H; Sartorius K; Emtestam L; Svensson Å
Dermatology; 2020; 236(4):281-288. PubMed ID: 32015234
[TBL] [Abstract][Full Text] [Related]
16. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
Denny G; Anadkat MJ
J Am Acad Dermatol; 2016 Sep; 75(3):632-634. PubMed ID: 27543219
[No Abstract] [Full Text] [Related]
17. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.
Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC
JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
Garg A; Birabaharan M; Strunk A
J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology.
Micheletti RG
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S48-50. PubMed ID: 25188457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
